(PanCAP)SynchronizationMatrix-COVID-19 Plan

The Defense Production Act. Read it here.

The president invoked the act Wednesday during a White House news briefing with members of the Coronavirus Task Force.

“It can do a lot of good things if we need it,” the president told reporters.

Image result for defense production act source

 

The 1950 act was periodically used during both the Korean War and throughout the Cold War, and was last invoked in June 2017 by Trump to provide technology in the space industrial base.

This is not about what the Federal government can provide, but rather the Federal government authorizing and hiring private business to produce products and service to fulfill the needs for the good of the nation. That is where innovation and capitalism works.

President Trump is pulling all the levers of government and plowing his way through regulations and bureaucracy. It is big and messy mostly because of Obamacare which installed 23000 pages of regulations. The PANCAP plan is found here in full. Additional levers are being created to stop the economic and financial damage the the nation.

Meanwhile, media has attacked President Trump for using the term ‘China virus’ and he defended that use, rightly so. The medical community uses several variations of the same phrase. It is about China and has been for decades. World leaders have challenged China for countless years over their reckless laws and lack of food, people, animal and health protections. I have seen it personally myself being in mainland China many years ago. I visited those wet markets where the food supply and lack of safety is not only disgusting but deadly. Truth be told, trafficking and breeding animals for food in China is estimated to be a $76 billion industry.

For perspective, this short video is a must watch.

Relations between the West and China has taken on a new attitude and approach and rightly so. The discussions should begin with China paying trillions in reparations to nations affected by not only the Covid-19 virus but even previous virus outbreaks as well. China holds an estimated $1.7 trillion of U.S. debt. China should forgive that debt today.

From an article written by Michael Auslin in part mentions:

Those concerned with global health issues may wonder why it is that China is wracked regularly by viral epidemics in addition to coronavirus, such as SARS, African Swine Fever, and avian flu (another outbreak is happening right now). Others may begin to look more carefully at China’s environmental devastation and the hundreds of thousands of premature deaths each year from air and water pollution.

On the trade side, many foreign corporations already have been reconsidering their operations in China, due to rampant intellectual property theft and rising production costs; now, they may seriously question how safe it is to continue to do business in China. Not only is the health of their employees at risk, but they no longer can be assured that China will be a stable supplier. If coronavirus becomes a seasonal phenomenon, as some experts predict, then even with a vaccine, new strains of the pathogen will always raise the specter of another out-of-control epidemic overwhelming the party-state’s capabilities and infecting the rest of the world.

China has a plan to be the world’s dominant power, what better way to achieve that mission than to infect the globe with a pandemic causing financial collapse? To prevent the China mission, Western nations must reassert nationalism including manufacturing and install policy that never allows vulnerabilities to health and national security, this includes 5G. China and Russia cannot be allowed to win much less have any kind of advantage over other nations.

U.S. citizens are very crafty, innovative and resourceful and given these skills and spirit, this will pass quickly.

 

COVID-19 Blame and Shame on Duke NUS Medical School

This is a very long read but since we are all sheltering in place, take the time to read it in full as it is jammed with fascinating facts. We have learned minute by minute due to media reporting all kinds of things about coronavirus but some REAL key facts have been omitted. Gotta ask why. We should start with Duke NUS Medical School/Singapore and domino from there. Doctors, scientists, lab techs, researchers and hunters all know very well the genesis of all potential 5000 strains of coronavirus and they collaborate and read published reports and discuss in seminars and educational events.

Lil Miss Shi knew as she is known as the bat-hunter in Wuhan. Beijing knew and kept quiet but Miss Shi did not. She warned for years and years and Duke University collaborated and likely the CDC and John Hopkins did also. Domestic biolabs and pharma all participate in the volumes of published reports and research.

Okay, read slowly and even take notes and list your questions.

Here we go.

Wuhan-based virologist Shi Zhengli has identified dozens of deadly SARS-like viruses in bat caves, and she warns there are more out there

By Jane Qiu

How China's "Bat Woman" Hunted Down Viruses from SARS to the New Coronavirus Shi Zhengli, known as China’s “bat woman” for her virus-hunting expeditions in bat caves, releases a fruit bat after taking blood and swab samples from it in 2004. Credit: Wuhan Institute of Virology

BEIJING—The mysterious patient samples arrived at Wuhan Institute of Virology at 7 P.M. on December 30, 2019. Moments later, Shi Zhengli’s cell phone rang. It was her boss, the institute’s director. The Wuhan Center for Disease Control and Prevention had detected a novel coronavirus in two hospital patients with atypical pneumonia, and it wanted Shi’s renowned laboratory to investigate. If the finding was confirmed, the new pathogen could pose a serious public health threat—because it belonged to the same family of bat-borne viruses as the one that caused severe acute respiratory syndrome (SARS), a disease that plagued 8,100 people and killed nearly 800 of them between 2002 and 2003. “Drop whatever you are doing and deal with it now,” she recalls the director saying.

Shi—a virologist who is often called China’s “bat woman” by her colleagues because of her virus-hunting expeditions in bat caves over the past 16 years—walked out of the conference she was attending in Shanghai and hopped on the next train back to Wuhan. “I wondered if [the municipal health authority] got it wrong,” she says. “I had never expected this kind of thing to happen in Wuhan, in central China.” Her studies had shown that the southern, subtropical areas of Guangdong, Guangxi and Yunnan have the greatest risk of coronaviruses jumping to humans from animals—particularly bats, a known reservoir for many viruses. If coronaviruses were the culprit, she remembers thinking, “could they have come from our lab?”

While Shi’s team at the Chinese Academy of Sciences institute raced to uncover the identity and origin of the contagion, the mysterious disease spread like wildfire. As of this writing, about 81,000 people in China have been infected. Of that number, 84 percent live in the province of Hubei, of which Wuhan is the capital, and more than 3,100 have died. Outside of China, about 41,000 people across more than 100 countries and territories in all of the continents except Antarctica have caught the new virus, and more than 1,200 have perished.

The epidemic is one of the worst to afflict the world in recent decades. Scientists have long warned that the rate of emergence of new infectious diseases is accelerating—especially in developing countries where high densities of people and animals increasingly mingle and move about.

“It’s incredibly important to pinpoint the source of infection and the chain of cross-species transmission,” says disease ecologist Peter Daszak, president of EcoHealth Alliance, a New York City–based nonprofit research organization that collaborates with scientists, such as Shi, around the world to discover new viruses in wildlife. An equally important task, he adds, is hunting down other related pathogens—the “known unknowns”—in order to “prevent similar incidents from happening again.”

Tracing the Virus at Its Source

To Shi, her first virus-discovery expedition felt like a vacation. On a breezy, sunny spring day in 2004, she joined an international team of researchers to collect samples from bat colonies in caves near Nanning, the capital of Guangxi. Her inaugural cave was typical of the region: large, rich in limestone columns and—being a popular tourist destination—easily accessible. “It was spellbinding,” Shi recalls, with milky-white stalactites hanging from the ceiling like icicles, glistening with moisture.

But the holidaylike atmosphere soon dissipated. Many bats—including several insect-eating species of horseshoe bats that are abundant in southern Asia—roost in deep, narrow caves on steep terrain. Often guided by tips from local villagers, Shi and her colleagues had to hike for hours to potential sites and inch through tight rock crevasses on their stomach. And the flying mammals can be elusive. In one frustrating week, the team explored more than 30 caves and saw only a dozen bats.

These expeditions were part of the effort to catch the culprit in the SARS outbreak, the first major epidemic of the 21st century. A Hong Kong team had reported that wildlife traders in Guangdong first caught the SARS coronavirus from civets, mongooselike mammals that are native to tropical and subtropical Asia and Africa.

Before SARS, the world had little inkling of coronaviruses—named because, seen under a microscope, their spiky surface resembles a crown—says Linfa Wang, who directs the emerging infectious diseases program at Singapore’s Duke-NUS Medical School. Coronavirues were mostly known for causing common colds. “The SARS outbreak was a game changer,” says Wang, whose work on bat-borne coronaviruses got a swift mention in the 2011 Hollywood blockbuster Contagion. It was the first time a deadly coronavirus with pandemic potential emerged. This discovery helped to jump-start a global search for animal viruses that could find their way into humans.

Shi was an early recruit of that worldwide effort, and both Daszak and Wang have since been her long-term collaborators. But how the civets got the virus remained a mystery. Two previous incidents were telling: Australia’s 1994 Hendra virus infections, in which the contagion jumped from horses to humans, and Malaysia’s 1998 Nipah virus outbreak, in which it moved from pigs to people. Both diseases were found to be caused by pathogens that originated in fruit-eating bats. Horses and pigs were merely the intermediate hosts.

In those first virus-hunting months in 2004, whenever Shi’s team located a bat cave, it would put a net at the opening before dusk—and then wait for the nocturnal creatures to venture out to feed for the night. Once the bats were trapped, the researchers took blood and saliva samples, as well as fecal swabs, often working into the small hours. After catching up on some sleep, they would return to the cave in the morning to collect urine and fecal pellets.

But sample after sample turned up no trace of genetic material from coronaviruses. It was a heavy blow. “Eight months of hard work seemed to have gone down the drain,” Shi says. “We thought coronaviruses probably did not like Chinese bats.” The team was about to give up when a research group in a neighboring lab handed it a diagnostic kit for testing antibodies produced by people with SARS.

There was no guarantee the test would work for bat antibodies, but Shi gave it a go anyway. “What did we have to lose?” she says. The results exceeded her expectations. Samples from three horseshoe bat species contained antibodies against the SARS virus. “It was a turning point for the project,” Shi says. The researchers learned that the presence of the coronavirus in bats was ephemeral and seasonal—but an antibody reaction could last from weeks to years. So the diagnostic kit offered a valuable pointer as to how to hunt down viral genomic sequences.

Shi’s team used the antibody test to narrow down locations and bat species to pursue in the quest for these genomic clues. After roaming mountainous terrain in the majority of China’s dozens of provinces, the researchers turned their attention to one spot: Shitou Cave on the outskirts of Kunming, the capital of Yunnan—where they conducted intense sampling during different seasons throughout five consecutive years.

The efforts paid off. The pathogen hunters discovered hundreds of bat-borne coronaviruses with incredible genetic diversity. “The majority of them are harmless,” Shi says. But dozens belong to the same group as SARS. They can infect human lung cells in a petri dish, cause SARS-like diseases in mice, and evade vaccines and drugs that work against SARS.

In Shitou Cave—where painstaking scrutiny has yielded a natural genetic library of bat viruses—the team discovered a coronavirus strain in 2013 that came from horseshoe bats and had a genomic sequence that was 97 percent identical to the one found in civets in Guangdong. The finding concluded a decade-long search for the natural reservoir of the SARS coronavirus.

Viral Melting Pots

In many bat dwellings Shi has sampled, including Shitou Cave, “constant mixing of different viruses creates a great opportunity for dangerous new pathogens to emerge,” says Ralph Baric, a virologist at the University of North Carolina at Chapel Hill. And in the vicinity of such viral melting pots, Shi says, “you don’t need to be a wildlife trader to be infected.”

Near Shitou Cave, for example, many villages sprawl among the lush hillsides in a region known for its roses, oranges, walnuts and hawthorn berries. In October 2015 Shi’s team collected blood samples from more than 200 residents in four of those villages. It found that six people, or nearly 3 percent, carried antibodies against SARS-like coronaviruses from bats—even though none of them had handled wildlife or reported SARS-like or other pneumonia-like symptoms. Only one had travelled outside of Yunnan prior to sampling, and all said they had seen bats flying in their village.

Three years earlier, Shi’s team had been called in to investigate the virus profile of a mineshaft in Yunnan’s mountainous Mojiang County—famous for its fermented Pu’er tea—where six miners suffered from pneumonialike diseases (two of them died). After sampling the cave for a year the researchers discovered a diverse group of coronaviruses in six bat species. In many cases, multiple viral strains had infected a single animal, turning it into a flying factory of new viruses.

“The mineshaft stunk like hell,” says Shi, who went in with her colleagues wearing a protective mask and clothing. “Bat guano, covered in fungus, littered the cave.” Although the fungus turned out to be the pathogen that had sickened the miners, she says it would only have been a matter of time before they caught the coronaviruses if the mine had not been promptly shut.

With growing human populations increasingly encroaching on wildlife habitats, with unprecedented changes in land use, with wildlife and livestock transported across countries and their products around the world, and with a sharp increase in both domestic and international travel, new disease outbreaks of pandemic scale are a near mathematical certainty. This had been keeping Shi and many other researchers awake at night—long before the mysterious samples landed at the Wuhan Institute of Virology on that ominous evening last December.

About a year ago, Shi’s team published two comprehensive reviews about coronaviruses in Viruses and Nature Reviews Microbiology. Drawing evidence from her own studies—many of which were published in top academic journals—and from others, Shi and her co-authors warned of the risk of future outbreaks of bat-borne coronaviruses.

Racing against a Deadly Pathogen

On the train back to Wuhan on December 30 last year, Shi and her colleagues discussed ways to immediately start testing the patient samples. In the following weeks—the most intense and the most stressful time of her life—China’s bat woman felt she was fighting a battle in her worst nightmare, even though it was one she had been preparing for over the past 16 years. Using a technique called polymerase chain reaction, which can detect a virus by amplifying its genetic material, the first round of tests showed that samples from five of seven patients contained genetic sequences known to be present in all coronaviruses.

Shi instructed her team to repeat the tests and, at the same time, sent the samples to another laboratory to sequence the full viral genomes. Meanwhile she frantically went through her own laboratory’s records from the past few years to check for any mishandling of experimental materials, especially during disposal. Shi breathed a sigh of relief when the results came back: none of the sequences matched those of the viruses her team had sampled from bat caves. “That really took a load off my mind,” she says. “I had not slept a wink for days.”

By January 7 the Wuhan team determined that the new virus had indeed caused the disease those patients suffered—a conclusion based on results from polymerase chain reaction analysis, full genome sequencing, antibody tests of blood samples and the virus’s ability to infect human lung cells in a petri dish. The genomic sequence of the virus—now officially called SARS-CoV-2 because it is related to the SARS pathogen—was 96 percent identical to that of a coronavirus the researchers had identified in horseshoe bats in Yunnan, they reported in a paper published last month in Nature. “It’s crystal clear that bats, once again, are the natural reservoir,” says Daszak, who was not involved in the study.

In 2004, an international team of scientists takes blood and swab samples from bats at night in order to discover potential bat-borne pathogens. Credit: Wuhan Institute of Virology

The genomic sequences of the viral strains from patients are, in fact, very similar to one another, with no significant changes since late last December, based on analyses of 326  published viral sequences. “This suggests the viruses share a common ancestor,” Baric says. The data also point to a single introduction into humans followed by sustained human-to-human transmission, researchers say.

Given that the virus seems fairly stable and that many infected individuals appear to have mild symptoms, scientists suspect the pathogen might have been around for weeks or even months before the first severe cases raised alarm. “There might have been mini outbreaks, but the virus burned out” before causing havoc, Baric says. “The Wuhan outbreak is by no means incidental.” In other words, there was an element of inevitability to it.

To many, the region’s burgeoning wildlife markets—which sell a wide range of animals such as bats, civets, pangolins, badgers and crocodiles—are perfect viral melting pots. Although humans could have caught the deadly virus from bats directly (according to several studies, including those by Shi and her colleagues), independent teams have suggested in preprint studies that pangolins may have been an intermediate host. These teams have reportedly uncovered SARS-CoV-2–like coronaviruses in these animals, which were seized in antismuggling operations in southern China.

On February 24 the nation announced a permanent ban on wildlife consumption and trade except for research or medicinal or display purposes—which will stamp out an industry worth $76 billion and put approximately 14 million people out of jobs, according to a 2017 report commissioned by the Chinese Academy of Engineering. Some welcome the initiative, whereas others, such as Daszak, worry that without efforts to change people’s traditional beliefs or provide alternative livelihoods, a blanket ban may push the business underground. This could make disease detection even more challenging. “Eating wildlife has been part of the cultural tradition in southern China” for thousands of years, Daszak says. “It won’t change overnight.”

In any case, Shi says, “wildlife trade and consumption are only part of problem.” In late 2016 pigs across four farms in Qingyuan county in Guangdong—60 miles from the site where the SARS outbreak originated—suffered from acute vomiting and diarrhea, and nearly 25,000 of the animals died. Local veterinarians could not detect any known pathogen and called Shi for help. The cause of the illness, called swine acute diarrhea syndrome (SADS), turned out to be a virus whose genomic sequence was 98 percent identical to a coronavirus found in horseshoe bats in a nearby cave.

“This is a serious cause for concern,” says Gregory Gray, an infectious disease epidemiologist at Duke University. Pigs and humans have very similar immune systems, making it easy for viruses to cross between the two species. Moreover a team at Zhejiang University in the Chinese city of Hangzhou found the SADS virus could infect cells from many organisms in a petri dish, including rodents, chickens, nonhuman primates and humans. Given the scale of swine farming in many countries, such as China and the U.S., Gray says, looking for novel coronaviruses in pigs should be a top priority.

Although the Wuhan outbreak is the sixth one caused by bat-borne viruses in the past 26 years —the other five being Hendra in 1994, Nipah in 1998, SARS in 2002, MERS (Middle East respiratory syndrome) in 2012, and Ebola in 2014—“the animals [themselves] are not the problem,” Wang says. In fact, bats help promote biodiversity and the health of their ecosystems by eating insects and pollinating plants. “The problem arises when we get in contact with them,” he says.

Fending Off Future Outbreaks

More than two months into the epidemic—and seven weeks after the Chinese government imposed citywide transportation restrictions in Wuhan, a megacity of 11 million—life feels almost normal, Shi says, laughing. “Maybe we are getting used to it. The worst days are certainly over.” The institute staffers have a special pass to travel from home to their laboratory, but they cannot go anywhere else. For more than a month, they had to subsist on instant noodles during their long hours in the lab because the institute’s canteen was closed.

The researchers found that the new coronavirus enters human lung cells using a receptor called angiotensin-converting enzyme 2 (ACE2). The scientists have since been screening for drugs that can block it. They, as well as other research groups, are also racing to develop vaccines and test promising candidates. In the long run, the team plans to develop broad-spectrum vaccines and drugs against coronaviruses deemed risky to humans. “The Wuhan outbreak is a wake-up call,” Shi says.

Many scientists say the world should move beyond merely responding to deadly pathogens when they arise. “The best way forward is prevention,” Daszak says. Because 70 percent of animal-borne emerging infectious diseases come from wild creatures, “where we should start is to find all those viruses in wildlife globally and develop better diagnostic tests,” he adds. Doing so would essentially mean rolling out what researchers such as Daszak and Shi have been doing on a much bigger scale.

Such efforts should focus on high-risk viral groups in certain mammals prone to coronavirus infections, such as bats, rodents, badgers, civets, pangolins, and nonhuman primates, Daszak says. He adds that developing countries in the tropics, where wildlife diversity is greatest, should be the front line of this battle against viruses.

In recent decades, Daszak and his colleagues analyzed approximately 500 human infectious diseases from the past century. They found that the emergence of new pathogens tended to happen in places where a dense population had been changing the landscape—by building roads and mines, cutting down forests and intensifying agriculture. “China is not the only hotspot,” he says, noting that other major emerging economies, such as India, Nigeria and Brazil, are also at great risk.

Once potential pathogens are mapped out, scientists and public health officials can regularly check for possible infections by analyzing blood and swab samples from livestock, wild animals that are farmed and traded, and high-risk human populations, such as farmers, miners, villagers who live near bats, and people who hunt or handle wildlife, Gray says. This approach, known as “One Health,”, aims to integrate the management of wildlife health, livestock health, and human health. “Only then can we catch an outbreak before it turns into an epidemic,” he says, adding that the approach could potentially save the hundreds of billions of dollars such an epidemic can cost.

Back in Wuhan, China’s bat woman has decided to retire from the front line of virus-hunting expeditions. “But the mission must go on,” says Shi, who will continue to lead research programs. “What we have uncovered is just the tip of an iceberg.” Daszak’s team has estimated that there are as many as 5,000 coronavirus strains waiting to be discovered in bats globally. Shi is planning a national project to systematically sample viruses in bat caves—with much greater scope and intensity than her team’s previous attempts.

“Bat-borne coronaviruses will cause more outbreaks,” she says with a tone of brooding certainty. “We must find them before they find us.”

 

 

FCC Investigates Adam Schiff for Subpoena Abuse

Okay cool, but what could be the consequence in the end is the real question.

During the House impeachment proceedings, Rep. Adam Schiff (D-CA) released a report which included the phone records that included calls made or received by Rep. Devin Nunes(R-CA), journalist John Solomon, Rudy Giuliani, and others. The records in the report didn’t contain the content of the conversations but included who called who and how long the call lasted.

Devin Nunes Responds To Adam Schiff “Subpoenaing” Private ... source

The belief was that the records were obtained through subpoenas to the phone companies of records related to Giuliani and Lev Parnas, with the obvious purpose meant to try to impugn the people whose records were included without reason or cause.

What made it especially troubling was Schiff wouldn’t explain who was subpoenaed or how, and if it was a Congressional subpoena straight to the companies, it was a troubling abuse of power.

 

Now, as Kim Strassel at the Wall Street Journal is reporting, the FCC Commissioner, Brendan Carr, is calling Schiff out over what he believes are abuses of his subpoena power and Carr wants answers. Strassel called it an “incredible abuse” with Schiff publishing call records of his political rivals including Nunes, even the President’s attorney, Rudy Giuliani. Schiff even smeared Nunes during a press conference with the records, trying to suggest that Nunes was somehow “complicit.”


While Carr acknowledged that there might be instances in which Schiff could subpoena call records, Carr said the problem was that Schiff did this in secret, without giving the people whose records were grabbed the opportunity to respond or fight the request.

If that’s allowed, that’s a tremendous abuse of power if members of Congress can just demand phone records from the phone company about any American without any court and without any check.

Carr sent Schiff’s House Intel Committee a formal letter not only calling out their prior actions, but indicating that Schiff/the Committee may still be getting people’s records.

Carr points out in his letter that Schiff isn’t allowed to get the records from the phone company without consent from the citizen or in accordance with the law — that there has to be judicial review. Nor did they establish any legitimate legislative purpose in subpoenaing the records.

Moreover, as Carr notes, the recent decision involving the subpoena to former White House Counsel Don McGahn has now established that the subpoena power of the Congress as to such things might be questionable, without a court check on possible abuse of power.

Yes, please. It’s about time. Carr mentions substantial fines in his letter but there may be further action that could be taken.

ImageView image on Twitter

 

Judge Rules Hillary et.al Must be Deposed

A Washington federal trial judge said Clinton and a former longtime aide must be deposed in a public-records suit about Clinton’s use of a private email server. The impending depositions are “inappropriate, unnecessary, and a clear abuse of discretion,” lawyers at Williams & Connolly and Wilkinson Walsh contend.

Petitioners: Hillary Rodham Clinton; Cheryl Mills. Respondents:Judicial Watch, Inc.; United States Department of State.

Truth is, this all started with gaining records/emails regarding Benghazi. The saga continues while the Hillary Clinton lawyer of record continues to be David Kendall. The Hillary legal team petition to the court to prevent the depositions is found here.

***

U.S. District Court Royce Lamberth, a Reagan appointee, said in court filings that written answers provided by Clinton to questions from Judicial Watch were “incomplete, unhelpful, or cursory, at best.”

“As extensive as the existing record is, it does not sufficiently explain Secretary Clinton’s state of mind when she decided it would be an acceptable practice to set up and use a private server to conduct State Department business,” Lamberth wrote in his order. “Simply put, her responses left many more questions than answers.”

“Even years after the FBI investigation, the slow trickle of new emails has yet to be explained,” the judge added, referring to the rate at which emails from Clinton’s private email server have since been released.

*** source

Clinton’s legal team responded with an 83-page petition for a writ of mandamus filed with the U.S. Court of Appeals for the D.C. Circuit, calling the district ruling outrageous and asking the appeals court to order the lower court to correct the ruling.

The legal team for Clinton said reversing the order “is warranted because Judicial Watch’s impending depositions of Secretary Clinton and Ms. Mills are inappropriate, unnecessary, and a clear abuse of discretion.”

Judicial Watch President Tom Fitton said, “This desperate act is yet another attempt by the Clinton machine to delay truth and accountability for her email conduct and how it impacted the people’s ‘right to know’ under FOIA.”

Clinton’s lead attorney David Kendall said, “The district court’s order inappropriately discounts this Court’s prior finding that there are no remaining recoverable emails, the extraordinary discovery that Judicial Watch has already obtained, and the vast public record on Secretary Clinton’s emails.” He claimed, “Judicial Watch could not possibly show the extraordinary circumstances required to depose (or re-depose) former high-ranking officials regarding their reasons for taking official actions, and the court abused its discretion in finding otherwise.”

The Clinton team laid out three main arguments for why the lower court’s order should be reversed. First, they referenced a prior D.C. appeals court ruling in a Judicial Watch v. Pompeo case in 2018 that they said should render this FOIA case “moot.” Next, they claimed the district court’s order “violates the well-established principle that high-ranking government officials should not be subjected to depositions absent extraordinary circumstances.” And they claimed the lower court “lacked jurisdiction to order additional discovery because the FOIA requests were submitted only after Secretary Clinton left office.”

The district court ruling earlier this month was the latest twist in a nearly six-year-long case related to Clinton’s reasons for setting up her unauthorized private email server and whether she was attempting to avoid Freedom of Information Act requests.

Lamberth listed some remaining questions for Clinton: “How did she arrive at her belief that her private server emails would be preserved by normal State Department processes for email retention? … Did she realize State was giving ‘no records’ responses to her FOIA requests for emails? … And why did she think that using a private server to conduct State Department business was permissible under the law in the first place?”

The FBI investigated Clinton’s use of the server, hosted in the basement of her home in Chappaqua, New York, while she was secretary of state from 2009 to 2014. Although former FBI Director James Comey found that Clinton was “extremely careless” in handling classified emails, no criminal charges were recommended against anyone following the bureau’s “Midyear Exam” investigation.

“Judicial Watch argued that Secretary Clinton’s existing testimony has only scratched the surface of the inquiry into her motives for setting up and using a private server,” Lamberth said.

The judge said Clinton’s written answers to questions in this case and related ones “were either incomplete, unhelpful, or cursory at bes,” and that “her responses left many more questions than answers.”

 

First Covid-19 Vaccine code-named mRNA-1273 Shot Given

At a news conference, President Donald Trump praised how quickly the research had progressed. Fauci noted that 65 days have passed since Chinese scientists shared the virus’ genetic sequence. He said he believed that was a record for developing a vaccine to test.

Seattle: This vaccine candidate, code-named mRNA-1273, was developed by the NIH and Massachusetts-based biotechnology company Moderna Inc. There’s no chance participants could get infected because the shots do not contain the coronavirus itself.

It’s not the only potential vaccine in the pipeline. Dozens of research groups around the world are racing to create a vaccine against COVID-19. Another candidate, made by Inovio Pharmaceuticals, is expected to begin its own safety study next month in the U.S., China and South Korea.

The Seattle experiment got underway days after the World Health Organization declared the new virus outbreak a pandemic because of its rapid global spread, which has infected more than 169,000 people and killed more than 6,500. AP reporter(s) witnessed the first human trial on Monday.

***

Other medical procedures are underway in hundreds of forms to combat the Covid-19 outbreak.

A very old drug developed by a scientist in 1934 for Bayer discovered chloroquine for malaria. It was widely used during World War ll and has been extensively used for SARS with excellent results. Its history goes back to Peru (South America), where the indigenous people extracted the bark of the Cinchona trees and used the extract (Chinchona officinalis) to fight chills and fever in the seventeenth century. In 1633 this herbal medicine was introduced in Europe, where it was given the same use and also began to be used against malaria.

We report on chloroquine, a 4-amino-quinoline, as an effective inhibitor of the replication of the severe acute respiratory syndrome coronavirus (SARS-CoV) in vitro. Chloroquine is a clinically approved drug effective against malaria.

It was reported a few weeks ago that officials in China were not cooperating with other nations at the outset of Covid-19. That is only partially true. The U.S. has collaborated with scientists and medical experts in China since SARS and continues to do so with very positive results.

Data from the drug’s studies showed ‘certain curative effect’ with ‘fairly good efficacy’.

According to Sun, patients treated with chloroquine demonstrated a better drop in fever, improvement of lung CT images, and required a shorter time to recover compared to parallel groups.

The percentage of patients with negative viral nucleic acid tests was also higher with the anti-malarial drug.

Chloroquine has so far showed no obvious serious adverse reactions in the more than 100 participants in the trials.

The China National Center for Biotechnology Development head Zhang Xinmin said that chloroquine is one of the three drugs that have a promising profile against the new coronavirus, reported China Daily.

The remaining two drugs are anti-flu medicine favipiravir and Gilead’s investigational anti-viral candidate remdesivir.

Favipiravir is currently in a 70-patient trial in Shenzhen, Guangdong province, while remdesivir is under evaluation at more than ten medical institutions in Wuhan.

In trials conducted in China, chloroquine appears to be useful for coronavirus disease 2019. Another form is Hydroxychloroquine.

Hydroxychloroquine Sulfate (Watson Laboratories, Inc ...

Hydroxychloroquine is also presecribed for HIV, arthritis as well as advanced malaria and strains of coronavirus. It is a disease-modifying anti-rheumatic drug (DMARD).It regulates the activity of the immune system, which may be overactive in some conditions.

A small 40 cents, that is $.40 a dose to make and is generally sold for $5.00 per dose.